The Patent Finder

Siwa Corporation

17 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Nov 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 23, 2027
    The maintenance fee for Product and method for treating sarcopenia (US 10,358,502) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
  • 1 fee due Apr 20, 2027
    The maintenance fee for Methods, compositions and apparatuses for facilitating regeneration (US 9,161,810) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Method and composition for treating cancer, killing metastatic cancer cells and preventing cancer metastasis using antibody to advanced glycation end products (AGE) (US 11,833,202) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 2 fees due Jul 16, 2027
  • 1 fee due Sep 10, 2027
    The maintenance fee for Anti-AGE antibodies for treating inflammation and auto-immune disorders (US 10,584,180) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 2 fees due Oct 16 to 26, 2027 · next Oct 16

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,320,919Selective removal of cells having accumulated agents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,161,810Methods, compositions and apparatuses for facilitating regeneration
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,226,531Selective Removal of Age-Modified Cells for Treatment of Atherosclerosis
In force
 · Low confidence
In forceLow confidence
US 9,649,376Selective removal of age-modified cells for treatment of atherosclerosis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,584,180Anti-AGE antibodies for treating inflammation and auto-immune disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,889,634Anti-age antibodies and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,873,345Product and method for treating sarcopenia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,358,502Product and method for treating sarcopenia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,872,269Method and composition for treating sarcopenia
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,958,900Anti-age antibodies for treating neurodegenerative disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
Also on record, not counted in the 17: 8 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 10 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited